Doxepin Tablet
Product Images NDC 72578-182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin (NDC 72578-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Doxepin Tablets, 3 mg (4e781c2d E54c 46cb A10f 9b37097e090a 02)
This is a description of Doxepin Tablets which contain 3.39 mg Doxepin Hydrochloride, USP equivalent to 3 mg of Doxepin per tablet. The usual dosage information can be found in the package insert. The tablets come in a child-resistant package and should be stored at 20°C to 25°C. They are dispensed by Viona Pharmaceuticals Inc. and manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India. A Medication Guide is available for patients either online or by calling a specific phone number.*
Doxepin Tablets, 6 mg (4e781c2d E54c 46cb A10f 9b37097e090a 03)
Each tablet of this medication contains 6.78 mg of Doxepin Hydrochloride, USP, which is equivalent to 6 mg of Doxepin. The typical dosage information can be found in the package insert. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) while being protected from light. The medication should be dispensed with a Medication Guide in a tight, light-resistant container, and kept out of the reach of children. For more details, visit the website or contact the provided phone number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.